Literature DB >> 11813170

Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood.

Gordan M Vujanić1, Bengt Sandstedt, Dieter Harms, Anna Kelsey, Ivo Leuschner, Jan de Kraker.   

Abstract

The previous International Society of Paediatric Oncology (SIOP) trials and studies recognized three prognostic groups of renal tumors of childhood: low risk, intermediate risk, and high risk tumors, which were further defined in the SIOP (Stockholm) Working Classification of Renal Tumors of Childhood (1994). The results of the latest SIOP Trials and Studies showed that certain histological features which remain after preoperative chemotherapy, such as blastema, are of prognostic significance while others are not. Therefore, in the next SIOP Trials and Study a revised classification of renal tumors will be followed. It still recognizes the three tumor risk groups with different types in each of them, but for treatment purposes, only three major types of nephroblastoma need to be recognized: completely necrotic (low risk tumor), blastemal (high risk tumor), and others (intermediate risk tumors). Patients will be treated according to tumor histology and stage. Trials which include preoperative chemotherapy have shown that the presence of necrotic tumor or chemotherapy induced changes in the renal sinus or perirenal fat can be ignored for distinguishing between stage I and II, but if present at resection margins or lymph nodes, it should be regarded as stage III. Prognostic significance of all histological component of Wilms tumors will be studied prospectively in the new trial. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11813170     DOI: 10.1002/mpo.1276

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  70 in total

1.  Botryoid Wilms tumor: a non-existent "entity" causing diagnostic and staging difficulties.

Authors:  Gordan M Vujanić; Marco Schiavo Lena; Neil J Sebire
Journal:  Virchows Arch       Date:  2018-12-04       Impact factor: 4.064

2.  Omitting pulmonary radiotherapy in selected stage IV nephroblastoma patients with pulmonary metastases.

Authors:  Marry M van den Heuvel-Eibrink; Saskia L Gooskens; Filippo Spreafico
Journal:  Transl Pediatr       Date:  2013-01

3.  Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.

Authors:  Richard D Williams; Reem Al-Saadi; Tasnim Chagtai; Sergey Popov; Boo Messahel; Neil Sebire; Manfred Gessler; Jenny Wegert; Norbert Graf; Ivo Leuschner; Mike Hubank; Chris Jones; Gordan Vujanic; Kathy Pritchard-Jones
Journal:  Clin Cancer Res       Date:  2010-03-23       Impact factor: 12.531

4.  Patterns of shift in ADC distributions in abdominal tumours during chemotherapy-feasibility study.

Authors:  Kirsteen McDonald; Neil J Sebire; John Anderson; Oystein E Olsen
Journal:  Pediatr Radiol       Date:  2010-07-02

5.  [Imaging of abdominal tumors in childhood and adolescence : Part II: relevant intra-abdominal and retroperitoneal tumor entities].

Authors:  D M Renz; H-J Mentzel
Journal:  Radiologe       Date:  2018-07       Impact factor: 0.635

6.  Automatic generation of three-dimensional dose reconstruction data for two-dimensional radiotherapy plans for historically treated patients.

Authors:  Ziyuan Wang; Marco Virgolin; Peter A N Bosman; Koen F Crama; Brian V Balgobind; Arjan Bel; Tanja Alderliesten
Journal:  J Med Imaging (Bellingham)       Date:  2020-02-03

7.  Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.

Authors:  Conrad V Fernandez; Elizabeth A Mullen; Yueh-Yun Chi; Peter F Ehrlich; Elizabeth J Perlman; John A Kalapurakal; Geetika Khanna; Arnold C Paulino; Thomas E Hamilton; Kenneth W Gow; Zelig Tochner; Fredric A Hoffer; Janice S Withycombe; Robert C Shamberger; Yeonil Kim; James I Geller; James R Anderson; Paul E Grundy; Jeffrey S Dome
Journal:  J Clin Oncol       Date:  2017-12-06       Impact factor: 44.544

Review 8.  Stroma-predominant Wilms tumor with teratoid features: report of a rare case and review of the literature.

Authors:  Ruchika Gupta; Alok Sharma; Raman Arora; Amit Kumar Dinda
Journal:  Pediatr Surg Int       Date:  2009-01-29       Impact factor: 1.827

9.  Management of Wilms' tumor: NWTS vs SIOP.

Authors:  Sushmita Bhatnagar
Journal:  J Indian Assoc Pediatr Surg       Date:  2009-01

10.  Wilms' tumor: An update.

Authors:  Hemant B Tongaonkar; Sajid S Qureshi; Purna A Kurkure; Mary-Ann A Muckaden; Brijesh Arora; Thyavihalli B Yuvaraja
Journal:  Indian J Urol       Date:  2007-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.